TipRanks
Go Ultimate55% OFF

China SXT Pharmaceuticals (2RY3) Balance Sheet

China SXT Pharmaceuticals Balance Sheet

China SXT Pharmaceuticals's total assets for Q4 2026 were $34.75M, an increase of 0.00% from the previous quarter. DE:2RY3 total liabilities were $5.05M for the fiscal quarter, a 0.00% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetMar 26Mar 25Mar 24Mar 23Mar 22
$ 34.75M$ 21.66M$ 23.13M$ 29.55M$ 33.55M
$ 5.05M$ 6.22M$ 9.20M$ 14.86M$ 17.12M
$ 29.71M$ 15.44M$ 13.93M$ 14.69M$ 16.42M

Currency in USD

China SXT Pharmaceuticals Debt to Assets

015M30M45M0 %25 %50 %75 %LiabilitiesDebt to Assets2017201820192020202120222023202420252026AssetsLiabilitiesDebt to Assets